Federated Hermes, Inc. (FHI)
NYSE: FHI · Investment Advice · Pittsburgh, PA · filing with the SEC since 1998
Grade6.7
◀ Past 7.2● Present 7.1▶ Future 5.8
Who owns Federated Hermes, Inc.
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 6.4% of Class B Stock, as its SCHEDULE 13G/A filed Apr 17, 2025 says.
Directors and officers
14
report now, of 20 people on the record since 2005. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Class B Stock
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What FHI reports owning in othersstakes of 5% or more, and other ties
Minerva Neurosciences, Inc NERV
SCHEDULE 13G/A · filed Jul 8, 2026 · COMMON STOCK
LifeMD, Inc. LFMD
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK
EyePoint, Inc. EYPT
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK
Arcturus Therapeutics Holdings Inc. ARCT
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK
TTEC Holdings, Inc. TTEC
SCHEDULE 13G · filed Jan 8, 2026 · COMMON STOCK
aTyr Pharma, Inc. ATYR
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK
Advance Auto Parts Inc AAP
SCHEDULE 13G · filed Apr 7, 2026 · COMMON STOCK
MGP Ingredients, Inc. MGPI
SCHEDULE 13G/A · filed Jul 8, 2026 · COMMON STOCK · reported falling below 5%
Ovid Therapeutics Inc. OVID
SCHEDULE 13G/A · filed Jul 8, 2026 · COMMON STOCK · reported falling below 5%
Scynexis, Inc. SCYX
SCHEDULE 13G/A · filed Jul 20, 2026 · COMMON STOCK · reported falling below 5%
The other 5
IDEAYA Biosciences, Inc.
SCHEDULE 13G/A · filed Jan 8, 2026 · reported falling below 5%
SoundThinking, Inc.
SCHEDULE 13G/A · filed Apr 7, 2026 · reported falling below 5%
Smith Douglas Homes Corp.
SCHEDULE 13G/A · filed Apr 7, 2026 · reported falling below 5%
Virgin Galactic Holdings, Inc.
SCHEDULE 13G/A · filed Jun 4, 2025 · reported falling below 5%
Forte Biosciences, Inc.
SCHEDULE 13G/A · filed Sep 8, 2026 · reported falling below 5%
Other ties the annual report names
Rivington Energy Management Limited
A company bought · acquisition · Mar 2025 · owns, named in the 10-K filed Feb 27, 2026
68 subsidiaries in 8 countries, from the list filed with the 10-K filed Feb 27, 2026. Its Form 13F-HR for Jun 30, 2026 lists 2,039 holdings. The record carries no value for them.
Insider tradesForm 4
30sales
0purchases
0sales on a scheduled plan
10people selling
$12.4Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 9, 2025 to Nov 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window10 of 20 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Uhlman Paul A | Vice President | 6 | $5.5M | 0 | 0 | $0 |
| Nusseibeh Saker Anwar | CEO, Federated Hermes Limited | 8 | $2.2M | 0 | 0 | $0 |
| Donahue Thomas R | VP, CFO & Treasurer | 1 | $1.7M | 0 | 0 | $0 |
| Germain Peter J | EVP, CLO & Sec. | 4 | $900,000 | 0 | 0 | $0 |
| Novak Richard A | Principal Accounting Officer | 3 | $900,000 | 0 | 0 | $0 |
| Fisher John B | Vice President | 1 | $400,000 | 0 | 0 | $0 |
| Dudiak Dolores D | Vice President | 2 | $300,000 | 0 | 0 | $0 |
| Burke Bryan M | Vice President | 1 | $200,000 | 0 | 0 | $0 |
| Zierden Theodore W III | Vice President | 1 | $200,000 | 0 | 0 | $0 |
| Van Meter Stephen | VP, Chief Compliance Officer | 3 | $200,000 | 0 | 0 | $0 |